Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population

NCT ID: NCT02655432

Last Updated: 2016-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2016-01-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Screening of haitian children between the ages of 3 and 6 years old for amblyogenic risk factors with the use of the Spot photoscreener. The photoscreener results will be compared to the complete ophthalmologic evaluation. Primarily, this will allow evaluation of the performance of the spot photoscreener in the haitian children population. Secondarily, this study will gather epidemiological information on vision problems in the haitian children population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Screening of haitian children between the ages of 3 and 6 years old for amblyogenic risk factors with the use of the Spot photoscreener before and after cycloplegia. The photoscreener results will be compared to the complete ophthalmologic evaluation. The ophthalmologic evaluation includes visual acuity, ocular alignment, slit lamp evaluation, cycloplegic refraction and dilated fundus evaluation. First of all, this will allow evaluation of the performance of the spot photoscreener in the haitian children population. Second of all, this study will gather epidemiological information on vision problems in the haitian children population.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amblyopia Myopia Hyperopia Astigmatism Cataract Retinoblastoma Trachoma Xerophthalmia Glaucoma Retinopathy of Prematurity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Spot photoscreener

Automated vision screener: Spot Vision Screener VS 100, Welch-Allyn. This photoscreener is a portable device, using an infrared light. It is built to detect amblyogenic risk factors. First of all, the spot photoscreener produces a sounds which attracts the child's attention and helps him shift his gaze towards the device, held at 1 meter in front him. The spot then evaluates for refractive errors, anisocoria, strabismus, ptosis and media opacity. The ophthalmologic evaluation consists of the measure of the visual acuity, ocular alignment, anterior and posterior segment. The patient will be cyclopleged with cycloplegic drops and will be refracted to obtain a cyclopleged refraction. This will determine his refractive error.

Spot photoscreener

Intervention Type DEVICE

Screening of vision problem through an automated device

Ophthalmologic evaluation

Intervention Type PROCEDURE

Screening of vision problem through an ophthalmologic evaluation

Cyclopleged refraction

Intervention Type PROCEDURE

Screening of refractive problems through a cyclopleged optometric refraction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Spot photoscreener

Screening of vision problem through an automated device

Intervention Type DEVICE

Ophthalmologic evaluation

Screening of vision problem through an ophthalmologic evaluation

Intervention Type PROCEDURE

Cyclopleged refraction

Screening of refractive problems through a cyclopleged optometric refraction

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Haitian children aged 3-6 years of age
* Signed consent form from a legal guardian

Exclusion Criteria

* Previous vision problem diagnostic
* Unsigned consent form
Minimum Eligible Age

3 Years

Maximum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Université de Montréal

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Patrick Hamel

Hospital chef of the ophthalmology department, CHU Sainte-Justine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Antoine Sylvestre-Bouchard

Role: PRINCIPAL_INVESTIGATOR

Université de Montréal

Patrick Hamel, MD, FRCS

Role: STUDY_CHAIR

Université de Montréal

Christelle Doyon, MD

Role: STUDY_DIRECTOR

Université de Montréal

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

École Adventiste de Limbé

Lenbe, , Haiti

Site Status

ClinicA

Pétionville, , Haiti

Site Status

École Saint-Dominique de Plaine du nord

Plaine du Nord, , Haiti

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Haiti

References

Explore related publications, articles, or registry entries linked to this study.

Maida JM, Mathers K, Alley CL. Pediatric ophthalmology in the developing world. Curr Opin Ophthalmol. 2008 Sep;19(5):403-8. doi: 10.1097/ICU.0b013e328309f180.

Reference Type BACKGROUND
PMID: 18772673 (View on PubMed)

Resnikoff S, Pascolini D, Mariotti SP, Pokharel GP. Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull World Health Organ. 2008 Jan;86(1):63-70. doi: 10.2471/blt.07.041210.

Reference Type BACKGROUND
PMID: 18235892 (View on PubMed)

Braverman R. Diagnosis and treatment of refractive errors in the pediatric population. Curr Opin Ophthalmol. 2007 Sep;18(5):379-83. doi: 10.1097/ICU.0b013e328244dfed.

Reference Type BACKGROUND
PMID: 17700230 (View on PubMed)

Mathers M, Keyes M, Wright M. A review of the evidence on the effectiveness of children's vision screening. Child Care Health Dev. 2010 Nov;36(6):756-80. doi: 10.1111/j.1365-2214.2010.01109.x.

Reference Type BACKGROUND
PMID: 20645997 (View on PubMed)

Krumholtz I. Results from a pediatric vision screening and its ability to predict academic performance. Optometry. 2000 Jul;71(7):426-30.

Reference Type BACKGROUND
PMID: 15326895 (View on PubMed)

Atkinson J, Anker S, Nardini M, Braddick O, Hughes C, Rae S, Wattam-Bell J, Atkinson S. Infant vision screening predicts failures on motor and cognitive tests up to school age. Strabismus. 2002 Sep;10(3):187-98. doi: 10.1076/stra.10.3.187.8125.

Reference Type BACKGROUND
PMID: 12461713 (View on PubMed)

Williams WR, Latif AH, Hannington L, Watkins DR. Hyperopia and educational attainment in a primary school cohort. Arch Dis Child. 2005 Feb;90(2):150-3. doi: 10.1136/adc.2003.046755.

Reference Type BACKGROUND
PMID: 15665167 (View on PubMed)

Roch-Levecq AC, Brody BL, Thomas RG, Brown SI. Ametropia, preschoolers' cognitive abilities, and effects of spectacle correction. Arch Ophthalmol. 2008 Feb;126(2):252-8; quiz 161. doi: 10.1001/archophthalmol.2007.36.

Reference Type BACKGROUND
PMID: 18268218 (View on PubMed)

Lennerstrand G, Jakobsson P, Kvarnstrom G. Screening for ocular dysfunction in children: approaching a common program. Acta Ophthalmol Scand Suppl. 1995;(214):26-38; discussion 39-40. doi: 10.1111/j.1600-0420.1995.tb00585.x.

Reference Type BACKGROUND
PMID: 8574881 (View on PubMed)

Weinstock VM, Weinstock DJ, Kraft SP. Screening for childhood strabismus by primary care physicians. Can Fam Physician. 1998 Feb;44:337-43.

Reference Type BACKGROUND
PMID: 9512837 (View on PubMed)

Williams C, Harrad RA, Harvey I, Sparrow JM; ALSPAC Study Team. Screening for amblyopia in preschool children: results of a population-based, randomised controlled trial. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Ophthalmic Epidemiol. 2001 Dec;8(5):279-95. doi: 10.1080/09286586.2001.11644257.

Reference Type BACKGROUND
PMID: 11922382 (View on PubMed)

Williams C, Northstone K, Harrad RA, Sparrow JM, Harvey I; ALSPAC Study Team. Amblyopia treatment outcomes after screening before or at age 3 years: follow up from randomised trial. BMJ. 2002 Jun 29;324(7353):1549. doi: 10.1136/bmj.324.7353.1549.

Reference Type BACKGROUND
PMID: 12089090 (View on PubMed)

Fathy VC, Elton PJ. Orthoptic screening for three- and four-year-olds. Public Health. 1993 Jan;107(1):19-23. doi: 10.1016/s0033-3506(05)80488-3. No abstract available.

Reference Type BACKGROUND
PMID: 8475239 (View on PubMed)

Atkinson J, Braddick O, Robier B, Anker S, Ehrlich D, King J, Watson P, Moore A. Two infant vision screening programmes: prediction and prevention of strabismus and amblyopia from photo- and videorefractive screening. Eye (Lond). 1996;10 ( Pt 2):189-98. doi: 10.1038/eye.1996.46.

Reference Type BACKGROUND
PMID: 8776448 (View on PubMed)

Atkinson J, Braddick O, Nardini M, Anker S. Infant hyperopia: detection, distribution, changes and correlates-outcomes from the cambridge infant screening programs. Optom Vis Sci. 2007 Feb;84(2):84-96. doi: 10.1097/OPX.0b013e318031b69a.

Reference Type BACKGROUND
PMID: 17299337 (View on PubMed)

Kvarnstrom G, Jakobsson P, Lennerstrand G. Screening for visual and ocular disorders in children, evaluation of the system in Sweden. Acta Paediatr. 1998 Nov;87(11):1173-9. doi: 10.1080/080352598750031176.

Reference Type BACKGROUND
PMID: 9846920 (View on PubMed)

Kvarnstrom G, Jakobsson P, Lennerstrand G. Visual screening of Swedish children: an ophthalmological evaluation. Acta Ophthalmol Scand. 2001 Jun;79(3):240-4. doi: 10.1034/j.1600-0420.2001.790306.x.

Reference Type BACKGROUND
PMID: 11401631 (View on PubMed)

Eibschitz-Tsimhoni M, Friedman T, Naor J, Eibschitz N, Friedman Z. Early screening for amblyogenic risk factors lowers the prevalence and severity of amblyopia. J AAPOS. 2000 Aug;4(4):194-9. doi: 10.1067/mpa.2000.105274.

Reference Type BACKGROUND
PMID: 10951293 (View on PubMed)

Jewell G, Reeves B, Saffin K, Crofts B. The effectiveness of vision screening by school nurses in secondary school. Arch Dis Child. 1994 Jan;70(1):14-8. doi: 10.1136/adc.70.1.14.

Reference Type BACKGROUND
PMID: 8110000 (View on PubMed)

Cummings GE. Vision screening in junior schools. Public Health. 1996 Nov;110(6):369-72. doi: 10.1016/s0033-3506(96)80010-2.

Reference Type BACKGROUND
PMID: 8979754 (View on PubMed)

Williams C, Northstone K, Harrad RA, Sparrow JM, Harvey I; ALSPAC Study Team. Amblyopia treatment outcomes after preschool screening v school entry screening: observational data from a prospective cohort study. Br J Ophthalmol. 2003 Aug;87(8):988-93. doi: 10.1136/bjo.87.8.988.

Reference Type BACKGROUND
PMID: 12881342 (View on PubMed)

Snowdon SK, Stewart-Brown SL. Preschool vision screening. Health Technol Assess. 1997;1(8):i-iv, 1-83.

Reference Type BACKGROUND
PMID: 9483159 (View on PubMed)

Shamanna BR, Dandona L, Rao GN. Economic burden of blindness in India. Indian J Ophthalmol. 1998 Sep;46(3):169-72.

Reference Type BACKGROUND
PMID: 10085631 (View on PubMed)

Latorre-Arteaga S, Gil-Gonzalez D, Enciso O, Phelan A, Garcia-Munoz A, Kohler J. Reducing visual deficits caused by refractive errors in school and preschool children: results of a pilot school program in the Andean region of Apurimac, Peru. Glob Health Action. 2014 Feb 13;7:22656. doi: 10.3402/gha.v7.22656. eCollection 2014.

Reference Type BACKGROUND
PMID: 24560253 (View on PubMed)

Kedir J, Girma A. Prevalence of refractive error and visual impairment among rural school-age children of Goro District, Gurage Zone, Ethiopia. Ethiop J Health Sci. 2014 Oct;24(4):353-8. doi: 10.4314/ejhs.v24i4.11.

Reference Type BACKGROUND
PMID: 25489200 (View on PubMed)

Sommer A, Toureau S, Cornet P, Midy C, Pettiss ST. Xerophthalmia and anterior segment blindness. Am J Ophthalmol. 1976 Sep;82(3):439-46. doi: 10.1016/0002-9394(76)90492-x.

Reference Type BACKGROUND
PMID: 961794 (View on PubMed)

Duong HV, Westfield KC, Jones LS, Mitchell J, Carr T. A survey of ocular diseases in an isolated rural Haitian community: a retrospective evaluation. J Natl Med Assoc. 2012 Nov-Dec;104(11-12):536-43. doi: 10.1016/s0027-9684(15)30220-0.

Reference Type BACKGROUND
PMID: 23560356 (View on PubMed)

Courtright P, Hutchinson AK, Lewallen S. Visual impairment in children in middle- and lower-income countries. Arch Dis Child. 2011 Dec;96(12):1129-34. doi: 10.1136/archdischild-2011-300093. Epub 2011 Aug 24.

Reference Type BACKGROUND
PMID: 21868404 (View on PubMed)

Kirk S, Armitage MD, Dunn S, Arnold RW. Calibration and validation of the 2WIN photoscreener compared to the PlusoptiX S12 and the SPOT. J Pediatr Ophthalmol Strabismus. 2014 Sep-Oct;51(5):289-92. doi: 10.3928/01913913-20140701-01. Epub 2014 Jul 8.

Reference Type BACKGROUND
PMID: 25000209 (View on PubMed)

Silbert DI, Matta NS. Performance of the Spot vision screener for the detection of amblyopia risk factors in children. J AAPOS. 2014 Apr;18(2):169-72. doi: 10.1016/j.jaapos.2013.11.019.

Reference Type BACKGROUND
PMID: 24698615 (View on PubMed)

Arnold RW, Armitage MD. Performance of four new photoscreeners on pediatric patients with high risk amblyopia. J Pediatr Ophthalmol Strabismus. 2014 Jan-Feb;51(1):46-52. doi: 10.3928/01913913-20131223-02. Epub 2014 Jan 3.

Reference Type BACKGROUND
PMID: 24369683 (View on PubMed)

Sharma A, Congdon N, Patel M, Gilbert C. School-based approaches to the correction of refractive error in children. Surv Ophthalmol. 2012 May-Jun;57(3):272-83. doi: 10.1016/j.survophthal.2011.11.002. Epub 2012 Mar 6.

Reference Type BACKGROUND
PMID: 22398336 (View on PubMed)

Donahue SP, Arthur B, Neely DE, Arnold RW, Silbert D, Ruben JB; POS Vision Screening Committee. Guidelines for automated preschool vision screening: a 10-year, evidence-based update. J AAPOS. 2013 Feb;17(1):4-8. doi: 10.1016/j.jaapos.2012.09.012. Epub 2013 Jan 27.

Reference Type BACKGROUND
PMID: 23360915 (View on PubMed)

US Preventive Services Task Force. Vision screening for children 1 to 5 years of age: US Preventive Services Task Force Recommendation statement. Pediatrics. 2011 Feb;127(2):340-6. doi: 10.1542/peds.2010-3177. Epub 2011 Jan 31.

Reference Type BACKGROUND
PMID: 21282267 (View on PubMed)

Committee on Practice and Ambulatory Medicine and Section on Ophthalmology; American Academy of Pediatrics. Use of photoscreening for children's vision screening. Pediatrics. 2002 Mar;109(3):524-5. doi: 10.1542/peds.109.3.524.

Reference Type BACKGROUND
PMID: 11875154 (View on PubMed)

Arnold RW, Clausen M, Ryan H, Leman RE, Armitage D. Predictive value of inexpensive digital eye and vision photoscreening: "PPV of ABCD". Binocul Vis Strabismus Q. 2007;22(3):148-52.

Reference Type BACKGROUND
PMID: 17983349 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20160130

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

RetinaVue Diabetic Screening
NCT03343730 UNKNOWN NA